Sign in
4

Changes in Ownership

INSMED Inc Filed Acc 0001628280-25-004459

Chief Financial Officer sold 28,390 shares at $80.90 ($2,296,751)

  • Chief Financial Officer acquired 65,033 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Bonstein Sara · Chief Financial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-02-05 Grant or award : show line 1 in the form +65,033 183,896 D
2025-02-06 Sale : show line 2 in the form −28,390 $80.90 $2,296,751 155,506 D
Open-market sales · 28,390 sh · avg $80.90 · $2,296,751
Loading xslF345X05/wk-form4_1738966251.xml…